Gentian Diagnostics presents at the DNB Nordic Healthcare Conference

14. Dec 2023 | 1 min read

Moss, 14 December 2023

The CEO of Gentian Diagnostics, Dr. Hilja Ibert, will today give a company presentation at the DNB Nordic Healthcare conference.

Please find the presentation attached.

GDASA company presentation_DNB 2023

For further information, please contact:

Njaal Kind CFO, Gentian Diagnostics AS
E-mail: njaal.kind@gentian.no
+47 919 06 525

 

To see the announcement follow this link: https://newsweb.oslobors.no/message/606598

You may also read


Feb 12, 2026 - Ole Sørlie

Gentian Diagnostics: Key information relating to the proposed cash dividend

Moss, 12 February 2026 The Board of Directors of Gentian Diagnostics ASA proposes a dividend of NOK 0.60 per..

Feb 11, 2026 - Ole Sørlie

Update on the development of the NT-proBNP assay

Gentian Diagnostics ASA announces an update on the development of its NT proBNP assay. Recent investigations..

Feb 11, 2026 - Ole Sørlie

Gentian Diagnostics: Fourth quarter 2025 report

Moss, 11 February 2026 Gentian Diagnostics ASA, a fast-growing developer and manufacturer of diagnostic..